VIDAS TPSA, in vitro diagnostic, for use as an automated quantitative measurement of prostate specific antigen levels in human serum or plasma.
Published August 13, 2014 · Recall initiated: October 14, 2013
Summary
FDA records medical device Class II recall Z-2152-2014, published August 13, 2014 and initiated October 14, 2013. Recalling firm: BioMerieux SA; Status: Terminated; Reported quantity: 1902; Lot: Lot 1001904130. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Product is not approved or authorized for distribution in the US.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- BioMerieux SA
- Distributor
- FL, LA, MI, MS, NV, OH, OK, TN, TX
- Lot
- Lot 1001904130
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- France
Related recalls
- FDAEMAG system Model/Catalog Number: 418591/418591U Product Description: Nucleic acid sample preparationNovember 4, 2026
- FDAMYLA software. Used to manage microbiology test workflow from the reception of requests to the transmission ofAugust 18, 2021
- FDAVIDAS FSH, Ref 30407-01, IVD, Rx. The firm name on the label is bioMerieux SA, France. For use on theJuly 4, 2018
- FDAThe VITEK® 2 Gram Positive Susceptibility Card is intended for use with the VITEK 2 Systems in clinicalJune 20, 2018
- FDALatex Dental Dams labeled as Non-Latex Dental DamsAugust 13, 2014
- FDAPanthera-Puncher 9 . Panthera-Puncher 9 is a sample transfer instrument for professional use. The sample, aAugust 13, 2014
Questions about this recall
Was VIDAS TPSA, in vitro diagnostic, for use as an automated quantitative measurement of prostate specific antigen levels in human serum or plasma. recalled?
Yes. FDA published recall Z-2152-2014 on August 13, 2014. Reported hazard: Product is not approved or authorized for distribution in the US.
What should I do if I have this product?
Voluntary: Firm initiated · Letter